Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Heather Kistka

Neurological Surgery Elkhart, IN Medical Doctor

NPI 1144464850 CMS profile 1596490

500 Arcade Ave Ste 200, Elkhart, IN 46514

Open in the dashboard

General payments

$3,557

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heather Kistka of Elkhart, IN is reported in the CMS Open Payments database as having received $3,557 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $333 10
2024 General $256 6
2023 General $173 8
2022 General $480 20
2021 General $204 10
2020 General $223 8
2019 General $1,887 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heather Kistka
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Heather Kistka were reported at $333. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Heather Kistka Neurological Surgery median Middle half National median
2019 $1,887 $582 $138–$3,006 $163
2020 $223 $294 $76–$2,174 $114
2021 $204 $387 $105–$2,432 $132
2022 $480 $542 $139–$2,989 $149
2023 $173 $534 $145–$2,697 $160
2024 $256 $574 $155–$3,046 $164
2025 $333 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $1,148 10 payments
  2. Stryker Corporation $383 13 payments
  3. Providence Medical Technology, Inc. $376 10 payments
  4. Globus Medical, Inc. $326 15 payments
  5. Medtronic, Inc. $302 10 payments
  6. SI-BONE, Inc. $251 8 payments
  7. Orthofix Medical, Inc. $216 13 payments
  8. Zimmer Biomet Holdings, Inc. $106 4 payments
  9. Integra LifeSciences Corporation $61 2 payments
  10. Abbott Laboratories $58 1 payment
  11. Other $331 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,615 100 payments
  2. Travel and Lodging $942 3 payments
Products named General payments · program years 2019–2025
  1. O-ARM-ST $1,099 6 payments
  2. IFUSE IMPLANT $221 6 payments
  3. Excelsius - GPS $129 5 payments
  4. Spinal-Stim $124 7 payments
  5. AVIATOR $121 4 payments
  6. Spinal-Stim Osteogenesis Stimulator $91 6 payments
  7. CREO Fenestrated $66 1 payment
  8. Cervical-Stim Osteogenesis Stimulator $61 4 payments
  9. CUSA CLARITY $61 2 payments
  10. DURASEAL EXACT SPINAL SEALANT SYSTEM $61 2 payments
  11. Other $1,232 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

85

Median for Neurosurgery: 83

Drug cost

$1,424

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Duloxetine Hcl Generic 20 $427
Pregabalin Generic 13 $356
Cyclobenzaprine Hcl Generic 23 $331
Gabapentin Generic 29 $308

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$39,957

Medicare's payments for the services billed

Medicare patients

108

Average age 76

Services billed

231

63 women, 45 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Ischemic heart disease 40%
Diabetes 39%
Chronic kidney disease 29%
Osteoporosis 28%
Depression 27%
Heart failure 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record